http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2795418-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f4246e8fcebf17c365aced017a04c61 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate | 2013-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14867bf7573dc573e65f25248cb9195a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f51a95fc37a66342643edb941ae98b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae41a87cfbe2e8d4392abfdc04b91739 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d9eaaa8889e488ccdf3b51f0c74837 |
| publicationDate | 2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2795418-T3 |
| titleOfInvention | Peripherally restricted diphenyl purine derivatives |
| abstract | A compound according to the structure: ** (See formula) ** wherein: each R1, R2, and R3 is H or a substituent independently selected from the group consisting of F, Cl, Br, OH, optionally substituted C1-10 alkyl , optionally substituted C1-10 alkoxy, optionally substituted C2-4 alkenyl, optionally substituted C2-4 alkynyl, NR6R7, NR6COR7, NR6CO2R7, CR6R7OR8, CONR6R7, CO2R6, CN, CF3, NO2, N3, C1-3 alkylthio, R9SO, R9SO , CF3S, and CF3SO2; R4 and R5 taken together form a piperidine ring with the nitrogen atom to which they are attached, wherein the piperidine ring is substituted with a NR6SO2R9 or NR6CO2R7 substituent; and wherein the piperidine ring is optionally further substituted with one or more substituents independently selected from the group consisting of F, Cl, Br, I, OH, optionally substituted C1-10 alkyl, optionally substituted C1-10 alkoxy, C2-4 alkenyl optionally substituted, optionally substituted C2-4 alkynyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted alkaryl, NR6R7, NR6COR7, CR6R7OR8, CO2R6, CN, CF3, NO2, N3, C1-3 alkylthio, R9SO, R9SO2, CF3S, and CF3SO2, NR6SO2R9, NR6CONR7R11, NR6CO2R7, and CONR6R7; R6, R7, and R8 are independently selected from H and optionally substituted C1-10 alkyl; R9 is H or optionally substituted C1-10 alkyl; R11 is selected from the group consisting of H, optionally substituted C1-10 alkyl, and CR6R7CO2R8; and m and n are each independently integers from 0 to 5; or a pharmaceutically acceptable ester, amide, salt, solvate, or stereoisomer thereof. |
| priorityDate | 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 384.